Company profile: Trier Health
1.1 - Company Overview
Company description
- Provider of a smart, trusted and secure platform for digital clinical trial execution, supporting hybrid and 100% decentralized trials, enriching patient-clinician collaboration and patient engagement through analytics and deep AI, featuring VISION Recruit for AI-driven participant matching, outreach and scheduling, and VISION Engage for patient self-screening, self-scheduling, payments and profile management.
Products and services
- DeepCentric Platform: A secure platform enabling hybrid or 100% decentralized digital clinical trials, enriching patient‑clinician collaboration, boosting patient engagement via analytics, and instantly digitizing clinical data by applying deep AI
- VISION Recruit: An AI-driven platform that matches potential participants with clinical trials, automates outreach, and schedules appointments to accelerate enrollment workflows
- VISION Engage: A mobile app enabling patients to self-screen, self-schedule, receive payments, and manage profiles for clinical trials, streamlining participation tasks and communications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Trier Health
Cisiv
HQ: United Kingdom
Website
- Description: Provider of real-world data technology for pharmaceutical companies, including Baseline Plus for late-phase research with customizable workflows; a 21 CFR Part 11-compliant eConsent module integrated with Baseline Plus; patient apps for PROs, COAs, and eDiaries; electronic tools for observational studies; support for post-approval safety studies (PASS); and systems for retrospective chart reviews.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cisiv company profile →
DL Santé
HQ: France
Website
- Description: Provider of medical technological solutions, offering quality management software and inventory calculation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DL Santé company profile →
IDBS
HQ: United Kingdom
Website
- Description: Provider of advanced, cloud-based software for R&D organizations to securely capture, manage, share, and analyze structured and unstructured scientific data. Solutions include E-WorkBook (informatics platform for R&D), Polar (BioPharma Lifecycle Management), PIMS (process and quality data backbone), and ActivityBase (high-throughput screening data management).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IDBS company profile →
Tecan
HQ: Switzerland
Website
- Description: Provider of automated laboratory instruments and workflow solutions for clinical diagnostics, basic and translational research, and drug discovery. Offerings include Fluent and Freedom EVO liquid handling platforms, Spark multifunctional microplate reader, HydroFlex microplate washer, Trio RNA-Seq Kit, and Te-Care service contracts for maintenance, repair, and support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tecan company profile →
Strateos
HQ: United States
Website
- Description: Provider of SaaS-based robotic solutions for biology labs, offering the Strateos Cloud Lab for remote experiment design, execution, and analysis; lab automation software to manage instruments and workflows via the cloud; design and build services for modular smart labs; AI for drug discovery; discovery biology services; and automated small molecule drug discovery workflows.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Strateos company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Trier Health
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Trier Health
2.2 - Growth funds investing in similar companies to Trier Health
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Trier Health
4.2 - Public trading comparable groups for Trier Health
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →